Global Metachromatic Leukodystrophy (MLD) Treatment Market Report By Type (AGT-183, DUOC-01, GSK-2696274, Others), By Application (Hospital, Clinic, Others), And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

Name: Global Metachromatic Leukodystrophy (MLD) Treatment Market Report
Brand: Value Market Research
SKU: Healthcare
Price: 3950.00 USD
Availability: OnlineOnly
Rating: 4.2 (80 reviews)

ID:VMR11212390

April 2021

Report Formats: Electronic (PDF), MS EXCEL

Description
Table Of Content

The global demand for Metachromatic Leukodystrophy (MLD) Treatment Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% during the period of 2022-2028.

Metachromatic Leukodystrophy is a genetic disorder caused by a lack of an important enzyme in the blood called Arylsulfatase-A. It affects the white matter, or myelin, of the brain and the central nervous system. There are three types of MLD: late-infantile MLD, juvenile MLD, and adult MLD. Currently, there is no cure for MLD but symptoms can be well-managed. Bone marrow or cord blood transplantation has been found effective treating MLD. Many therapeutics are under reaserch among which gene therapy is one of promising one.

Market Dynamics

Metachromatic Leukodystrophy is a rare disease reported to occur in one in 40,000 to 160,000 people worldwide. The prevalence is greater in certain genetically isolated populations. Rise in awareness about diseases in developed as well as developing regions is likely to fuel the growth of global metachromatic leukodystrophy treatment market The therapeutic options available for treating MLD is limited but is predicted to expand with a number of early stages of clinical trials in progress. Since MLD is caused by defective ASA, most therapeutic approaches are focussed on correcting the biochemical defect by providing wild-type ASA. Gene therapy is one of the promising therapeutic for MLD. But during therapeutic research, the scientist has been facing many challenges that include blood-brain barrier (BBB) penetration, uncertainty regarding the ideal timing for intervention in the disease course, safety issues concerning therapies targeting the central nervous system, and the lack of more in-depth understanding of the molecular pathogenesis of MLD.

The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.

Additionally, these tools also give inclusive assessment of each application/product segment in the global market of metachromatic leukodystrophy (mld) treatment.

Market Segmentation

The entire metachromatic leukodystrophy (mld) treatment market has been sub-categorized into type and application. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.

By Type

AGT-183
DUOC-01
GSK-2696274
Others

By Application

Hospital
Clinic
Others

Regional Analysis

This section covers regional segmentation which accentuates on current and future demand for metachromatic leukodystrophy (mld) treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

Global Metachromatic Leukodystrophy (MLD) Treatment Market Share by Region (Representative Graph)

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the metachromatic leukodystrophy (mld) treatment market include ArmaGen Inc., GlaxoSmithKline Plc, Recursion Pharmaceuticals Inc., RegenxBio Inc., Shire Plcs. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY
       2.1. Highlights of Metachromatic Leukodystrophy (Mld) Treatment Market
       2.2. Global Metachromatic Leukodystrophy (Mld) Treatment Market Snapshot

3 . METACHROMATIC LEUKODYSTROPHY (MLD) TREATMENT – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Metachromatic Leukodystrophy (Mld) Treatment Market
       3.3. Market Restraints of Metachromatic Leukodystrophy (Mld) Treatment Market
       3.4. Opportunities of Metachromatic Leukodystrophy (Mld) Treatment Market
       3.5. Trends of Metachromatic Leukodystrophy (Mld) Treatment Market
       3.6. Porter’s Five Force Analysis of Metachromatic Leukodystrophy (Mld) Treatment Market
       3.7. Metachromatic Leukodystrophy (Mld) Treatment Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Type
           3.7.2 Market Attractive Analysis by Application
           3.7.3 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS
       4.1. Metachromatic Leukodystrophy (Mld) Treatment Value Chain Analysis
       4.2. Metachromatic Leukodystrophy (Mld) Treatment Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Metachromatic Leukodystrophy (Mld) Treatment Raw Material Manufactures List
           4.2.3. Price Trend of Metachromatic Leukodystrophy (Mld) Treatment Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak on Metachromatic Leukodystrophy (Mld) Treatment Market
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Metachromatic Leukodystrophy (Mld) Treatment Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Metachromatic Leukodystrophy (Mld) Treatment Market Size in 2020, by Scenario
       5.5. COVID-19: Micro and Macro Factor Analysis on Metachromatic Leukodystrophy (Mld) Treatment Market

6 . GLOBAL METACHROMATIC LEUKODYSTROPHY (MLD) TREATMENT MARKET ANALYSIS BY TYPE
       6.1 Overview by Type
       6.2 Global Metachromatic Leukodystrophy (Mld) Treatment Market Analysis by Type
       6.3 Market Analysis of AGT-183 by Regions
       6.4 Market Analysis of DUOC-01 by Regions
       6.6 Market Analysis of GSK-2696274 by Regions
       6.5 Market Analysis of Others by Regions

7 . GLOBAL METACHROMATIC LEUKODYSTROPHY (MLD) TREATMENT MARKET ANALYSIS BY APPLICATION
       7.1 Overview by Application
       7.2 Global Metachromatic Leukodystrophy (Mld) Treatment Market Analysis by Application
       7.3 Market Analysis of Hospital by Regions
       7.4 Market Analysis of Clinic by Regions
       7.5 Market Analysis of Others by Regions

8 . GLOBAL METACHROMATIC LEUKODYSTROPHY (MLD) TREATMENT MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview
           8.3.2. North America Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Market Segment
           8.3.3. North America Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Country
           8.3.4. United State
           8.3.5. Rest of North America
       8.4. Europe
           8.4.1. Overview
           8.4.2. Europe Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Market Segment
           8.4.3. Europe Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.8 Rest of Europe
       8.5. Asia Pacific
           8.5.1. Overview
           8.5.2. Asia Pacific Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Market Segment
           8.5.3. Asia Pacific Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Country
           8.5.4. China
           8.5.5. Japan
           8.5.6. India
           8.5.8. Rest of Asia Pacific
       8.6. Latin America
           8.6.1. Overview
           8.6.2. Latin America Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Market Segment
           8.6.3. Latin America Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Country
           8.6.4. Brazil
           8.6.5. Rest of Latin America
       8.8. Middle East & Africa
           8.8.1. Overview
           8.8.2. Middle East & Africa Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Market Segment
           8.8.3. Middle East & Africa Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Country
           8.8.4. Middle East
           8.8.5. Africa

9 . COMPETITIVE LANDSCAPE OF THE METACHROMATIC LEUKODYSTROPHY (MLD) TREATMENT COMPANIES
       9.1. Metachromatic Leukodystrophy (Mld) Treatment Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments

10 . COMPANY PROFILES OF METACHROMATIC LEUKODYSTROPHY (MLD) TREATMENT INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. ArmaGen Inc.
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. GlaxoSmithKline Plc
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. Recursion Pharmaceuticals Inc.
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. RegenxBio Inc.
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. Shire Plcs
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments

*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

LIST OF FIGURES

Research Scope of Metachromatic Leukodystrophy (Mld) Treatment Report
Market Research Process
Market Research Methodology
Global Metachromatic Leukodystrophy (Mld) Treatment Market Size, by Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis by Type
Market Attractiveness Analysis by Application
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Metachromatic Leukodystrophy (Mld) Treatment Market Analysis by Type (USD MN)
Global Metachromatic Leukodystrophy (Mld) Treatment Market Analysis in AGT-183 by Geography (USD MN)
Global Metachromatic Leukodystrophy (Mld) Treatment Market Analysis in DUOC-01 by Geography (USD MN)
Global Metachromatic Leukodystrophy (Mld) Treatment Market Analysis in GSK-2696274 by Geography (USD MN)
Global Metachromatic Leukodystrophy (Mld) Treatment Market Analysis in Others by Geography (USD MN)
Global Metachromatic Leukodystrophy (Mld) Treatment Market Analysis by Application (USD MN)
Global Metachromatic Leukodystrophy (Mld) Treatment Market Analysis in Hospital by Geography (USD MN)
Global Metachromatic Leukodystrophy (Mld) Treatment Market Analysis in Clinic by Geography (USD MN)
Global Metachromatic Leukodystrophy (Mld) Treatment Market Analysis in Others by Geography (USD MN)
Latin America Metachromatic Leukodystrophy (Mld) Treatment Market by Revenue
Middle East & Africa Metachromatic Leukodystrophy (Mld) Treatment Market by Revenue
Recent Development in Metachromatic Leukodystrophy (Mld) Treatment Industry
Company Market Share Analysis

* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

Buy sections of this report
Buy country level reports
Request for historical data
Request discounts available for Start-Ups & Universities

Request for Special Pricing

Objectives of Study

Define and measure the global market
Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
Analyze and identify major market trends along with the factors driving or inhibiting the market growth
Study the company profiles of the major market players with their market share
Analyze competitive developments

Why Choose Us

Client First Policy

Excellent Quality

After Sales Support

24/7 Email Support

Clients

Testimonials

" Doing business with Value Market Research was – quick, easy and accurate. We got what we expected. The team was very helpful and processes were altered for our convenience. The whole process from understanding our niche requirements to delivery to after sales was excellent. "

Vincenzo Baydar – Head Planning, Leading Food Chain, US

" Excellent work!! Working with you has been easy and direct. Your flexibility to alter the report scope and timely delivery assisted me in delivering my project proposal on time. "

Mia Tang, Director - Business Strategy, Steel Industry, Germany

" This is our second purchase and we have been obliged by the service. We appreciate the efforts put by Value Market Research in terms of understanding our needs, expanding the scope of the study, delivery and handling after sales queries. "